Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study. Reumatismo [Internet]. 2020 Apr. 10 [cited 2025 Jun. 26];72(1):52-9. Available from: https://www.reumatismo.org/reuma/article/view/1266